[HTML][HTML] Alteration of the esophageal microbiota in Barrett's esophagus and esophageal adenocarcinoma

J Lv, L Guo, JJ Liu, HP Zhao, J Zhang… - World journal of …, 2019 - ncbi.nlm.nih.gov
The incidence of esophageal adenocarcinoma (EAC) has increased in recent decades, and
its 5-year survival rate is less than 20%. As a well-established precursor, patients with …

Epidemiology, pathophysiology, and management of hepatorenal syndrome

AA Amin, EI Alabsawy, R Jalan, A Davenport - Seminars in Nephrology, 2019 - Elsevier
Acute kidney injury (AKI) is a common presentation in patients with advanced cirrhosis
hospitalized with acute decompensation. A new revised classification now divides AKI in …

[HTML][HTML] Controversies in acute kidney injury: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Conference

M Ostermann, R Bellomo, EA Burdmann, K Doi… - Kidney international, 2020 - Elsevier
In 2012, Kidney Disease: Improving Global Outcomes (KDIGO) published a guideline on the
classification and management of acute kidney injury (AKI). The guideline was derived from …

[HTML][HTML] Current approaches to the management of patients with cirrhotic ascites

DV Garbuzenko, NO Arefyev - World journal of gastroenterology, 2019 - ncbi.nlm.nih.gov
This review describes current approaches to the management of patients with cirrhotic
ascites in relation to the severity of its clinical manifestations. The PubMed database, the …

[HTML][HTML] Rifaximin improves survival in cirrhotic patients with refractory ascites: A real-world study

XY Lv, HG Ding, JF Zheng, CL Fan… - World journal of …, 2020 - ncbi.nlm.nih.gov
BACKGROUND Rifaximin has been shown to reduce the incidence of hepatic
encephalopathy and other complications in patients with cirrhosis. However, few studies …

An update on the pathogenesis and clinical management of cirrhosis with refractory ascites

SF Neong, D Adebayo, F Wong - Expert review of gastroenterology …, 2019 - Taylor & Francis
Introduction: Ascites commonly complicates cirrhosis, becoming refractory to treatment with
diuretics and sodium restriction in approximately 10% of patients. Pathogenesis of refractory …

Acute and non‐acute decompensation of liver cirrhosis (47/130)

MS Schulz, P Angeli, J Trebicka - Liver International, 2024 - Wiley Online Library
In the traditional view, the occurrence of cirrhosis‐related complications, such as hepatic
encephalopathy, formation of ascites or variceal haemorrhage, marks the transition to the …

Engineered apoptosis-bioinspired nanoparticles initiate Immune Cascade for Cancer Immunotherapy of Malignant ascites

A Huang, F Guo, Z Yu, P Liu, S Dong… - … Applied Materials & …, 2023 - ACS Publications
Malignant ascites (MA) is a common symptom of peritoneal metastasis in liver cancer.
Cancer immunotherapy can modulate immune cells to induce antitumor immune efficiency …

Inpatient mortality benefit with transjugular intrahepatic portosystemic shunt for hospitalized hepatorenal syndrome patients

P Charilaou, K Devani, R Petrosyan, C Reddy… - Digestive diseases and …, 2020 - Springer
Background It has been reported that transjugular intrahepatic portosystemic shunting
(TIPS) might be utilized as a salvage option for hepatorenal syndrome (HRS), while …

不同感染部位脓毒症急性肾损伤发生率及相关死亡风险分析

金魁, 王玉兰, 汪跃国, 朱云峰, 李雪芳, 朱家善… - 临床急诊 …, 2021 - lcjz.whuhzzs.com
目的: 探讨危重患者中不同感染部位对脓毒症相关急性肾损伤(SAKI) 发病率及相关死亡率的影响
, 并分析不同感染部位SAKI 发生的相关危险因素. 方法: 回顾性队列研究, 选择2018 年1 月 …